The Foreign Minister of Mexico, Marcelo Ebrand, formally announced this Wednesday that from Tuesday a total of 77 million Oxford / AstraZeneca vaccines will begin to arrive in Argentina and the rest of Latin America, the active part of which was manufactured in Argentina. . Ebrand, together with a group of journalists, visited the Liomond laboratory plant in the State of Mexico, and there he anticipated that the vaccines passed through the quality control of Cofepris, the Federal Commission for the Prevention of Sanitary Risks, in a way that the shipments will begin on May 25.
The project between the British laboratory, Argentina and Mexico was a strategic move by the government of Alberto Fernández. The production of the decisive part was made by mABxience, in Garín, in a plant owned by businessman Hugo Sigman. From there 50 million doses have already come out that did not have any inconvenience. But in Mexico, Liomont had several problems, among other things because the United States prohibited the export of essential filters to finish vaccines. Ebrand himself was the one who managed to overcome this obstacle in a negotiation with Washington. After that episode, there were difficulties in approving the quality controls carried out, extracting samples, by the laboratory that owns the vaccine, AstraZeneca.
–
The entire process produced a delay of two months, a vital time in times of pandemic. The vacuum was overcome by the Argentine government with the bet on the Sputnik V vaccine – a certainty of the ministers Ginés Gonzalez García, Carla Vizzotti and the presidential adviser Cecilia Nicolini – and the agreement that was reached with the Chinese vaccine Sinopharm. Now, as soon as the flow from Mexico begins, 22 million doses should arrive, which are those contracted by Argentina in that agreement.
The shipment of the first consignment from Mexico will have a formal presentation next Tuesday, May 25, in a kind of zoom act in which President López Obrador and President Fernández will be present.
– .
